LRRC15 and breast neoplasm: LEF1 enhancer facilitated Wnt pathway in tumor invasion [23], while LRRC15 protein, which was usually over-expressed in tumor, particularly breast tumors [24], was reported as a potential drug target for virus based cancer therapy [25].